Legato Capital Management’s CVS Health CVS Stock Holding History

Legato Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27,914	Closed	-$1.89M	–	574
2025 Q1	$1.89M	Hold	27,914	–	–	0.25%	112
2024 Q4	$1.25M	Buy	27,914 +2,470	+10%	+$139K	0.16%	221
2024 Q3	$1.6M	Sell	25,444 -36,307	-59%	-$2.12M	0.2%	163
2024 Q2	$3.65M	Sell	61,751 -5,754	-9%	-$360K	0.49%	30
2024 Q1	$5.38M	Hold	67,505	–	–	0.65%	20
2023 Q4	$5.33M	Buy	67,505 +7,635	+13%	+$543K	0.7%	17
2023 Q3	$4.18M	Hold	59,870	–	–	0.61%	29
2023 Q2	$4.14M	Buy	59,870 +27,206	+83%	+$1.94M	0.56%	26
2023 Q1	$2.43M	Buy	32,664 +1,272	+4%	+$107K	0.44%	48
2022 Q4	$2.93M	Buy	+31,392	New	+$3.03M	0.56%	31
2021 Q3	–	Sell	-33,023	Closed	-$2.75M	–	222
2021 Q2	$2.75M	Buy	+33,023	New	+$2.7M	0.39%	79

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Legato Capital Management's CVS Position: Q2 2025 in Review

Legato Capital Management sold out of CVS Health (CVS) in Q2 2025, closing a stake of 27,914 shares — an estimated $1.89M sold.

Legato Capital Management first reported a position in CVS in Q2 2021 and held it in 11 quarters. The position peaked at $5.38M in Q1 2024. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

Legato Capital Management reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
Legato Capital Management sold 27,914 CVS Health shares in Q2 2025, an estimated $1.89M.
Legato Capital Management first reported a position in CVS Health in Q2 2021 and held it in 11 quarters.
Legato Capital Management's CVS Health position peaked at $5.38M in Q1 2024.
1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Legato Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.